Alert detail

LCD L38067: MolDX: Next-Generation Sequencing for Solid Tumors — CGS

Policy ID: LCD-L38067Specialty: OncologyAdded: 6/5/2026Effective: August 21, 2025lcd
Routine

What changed

New NGS guidelines may reshape solid tumor testing billing.

Who’s affected: Oncology billing teams · Effective: August 21, 2025

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 18 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.